as declared in dailymail
The 13 NHS treatments at risk because of a controversial HIV drug PrEP
The 13 NHS treatments at risk because of a controversial HIV drug PrEP
Hundreds of people with rare diseases could miss out on vital treatments after the NHS was ordered to consider bankrolling a controversial HIV pill.Toddlers with cystic fibrosis, deaf children and amputees may now be denied a range of new medical devices and breakthrough drugs.NHS England has a budget of £25million a year for specialised new treatments and equipment for rare diseases.
let alone bbc
Call to fund Prep HIV drug on NHS
Call to fund Prep HIV drug on NHS
Image copyright Thinkstock Image caption Prep needs to be taken daily to build up resistance to HIVCalls are being made to get a drug that prevents HIV infection in people at high risk of the virus available on the NHS in Scotland.It follows legal battles in England over whether the NHS or local authorities should pay for it.The drug, described as a "game-changer" by experts, is used for a process known as pre-exposure prophylaxis, or Prep.
let alone aidsmap
HIV & AIDS Information :: The 'long tail' problem: forthcoming injected-PrEP efficacy trial delayed due to persistence of drug in some volunteers
HIV & AIDS Information :: The 'long tail' problem: forthcoming injected-PrEP efficacy trial delayed due to persistence of drug in some volunteers
The principal results of the ECLAIR study were announced at the Conference on Retroviruses and Opportunistic Infections (CROI 2016) last February.In brief, after a month taking oral cabotegravir to rule out short-term side-effects, 105 volunteers, all gay men aged 18 to 65 defined as being at low risk of HIV, were given three intramuscular injections of cabotegravir spaced 12 weeks apart, at 5, 17 and 29 weeks after the start of the study.Twenty-one other volunteers were given placebo pills/injections.
No comments:
Post a Comment